...Seiji Natsuki; Shigeru Lee; Hiroaki Kasashima; Yuichiro Miki; Tatsunari Fukuoka; Mami Yoshii; Tatsuro Tamura; Masatsune Shibutani; Takahiro Toyokawa; Hiroaki Tanaka; Maeda Kiyoshi Introduction: Nivolumab plus ipilimumab combination therapy has been administered as a first-line treatment in Japan...

... with unresectable stage III or stage IV melanoma treated with ipilimumab were included. We defined the baseline tumor burden (BTB) as the global sum of all metastases’ longest diameters before treatment started and correlated the calculated BTB with disease control rate (DCR), progression-free survival (PFS...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Hepatocellular carcinoma Nivolumab Pembrolizumab Ipilimumab Tremelimumab Clinical trials are currently ongoing...

... Neurosurgery Radiotherapy Radiosurgery Chemotherapy Temozolomide Bevacizumab Ipilimumab It is likely that, as our understanding of the processes broadly involved in CNS metastases are better understood, we will discover new means of treating and preventing CNS metastases. Common targets may exist...